Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study

CONCLUSIONS: DCCR administration to people with PWS was well-tolerated and associated with broad-ranging improvements in the syndrome. Sustained administration of DCCR has the potential to reduce disease severity and the burden of care for families.PMID:37919617 | DOI:10.1002/oby.23928

Source: Obesity - November 3, 2023 Category: Eating Disorders & Weight Management Authors: Jennifer L Miller Evelien Gevers Nicola Bridges Jack A Yanovski Parisa Salehi Kathryn S Obrynba Eric I Felner Lynne M Bird Ashley H Shoemaker Moris Angulo Merlin G Butler David Stevenson Anthony P Goldstone John Wilding Melissa Lah M Guftar Shaikh Elizabe Source Type: research